T45.522S Poisoning by antithrombotic drugs, intentional self-harm, sequela

Name of the Condition

• Poisoning by antithrombotic drugs, intentional self-harm, sequela (ICD-10 code T45.522S)

Summary

This condition represents the residual effects or complications following intentional self-harm involving antithrombotic drugs. Antithrombotic agents are used to prevent or treat blood clots, and intentional poisoning occurs when exposure is deliberate. The sequela designation indicates ongoing or chronic consequences resulting from the initial event.

Causes

Intentional self-harm may result from deliberate ingestion or administration of antithrombotic drugs. The sequela arises as a direct consequence of the initial poisoning, reflecting persistent clinical manifestations or functional impairment.

Risk Factors

• History of mental health conditions, such as depression or suicidal ideation.
• Access to antithrombotic medications in the home or clinical setting.
• Prior episodes of self-harm or overdose.
• Social or environmental stressors contributing to intentional actions.

Symptoms

• Chronic or recurrent bleeding (e.g., bruising, nosebleeds, gastrointestinal bleeding).
• Prolonged bleeding from minor injuries.
• Blood in urine or stool.
• Dizziness, weakness, or fatigue from blood loss.
• Possible signs of clotting abnormalities if underdosing occurs.

Diagnosis

Diagnosis involves reviewing medication history, assessing clinical signs of bleeding or clotting abnormalities, and conducting coagulation tests (e.g., INR, aPTT). Physical examination and lab results help determine the severity and persistence of effects.

Treatment Options

Treatment focuses on managing residual symptoms and preventing further complications. This may include ongoing monitoring, medication adjustments, or supportive care to address bleeding or clotting issues.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the effectiveness of subsequent management. Follow-up care is essential to monitor for recurrent symptoms, adjust therapies, and address underlying mental health concerns.

Complications

• Chronic bleeding or clotting disorders.
• Organ damage from prolonged bleeding or hypoxia.
• Psychological sequelae related to the self-harm event.
• Increased risk of future self-harm or overdose.

Lifestyle & Prevention

• Secure storage of antithrombotic medications to prevent access.
• Regular mental health evaluations for individuals with risk factors.
• Education on proper medication use and disposal.
• Support systems for managing stress or suicidal ideation.

When to Seek Professional Help

Seek immediate medical attention for signs of severe bleeding, dizziness, or weakness. Ongoing care is necessary for persistent symptoms or changes in health status.

Tips for Medical Coders

Document the nature of the sequela (e.g., chronic bleeding, organ damage) and its relationship to the initial intentional self-harm event. Ensure clinical details support the sequela designation and differentiate from acute poisoning.